Related Experiment Video
Updated: Jan 20, 2026

Author Spotlight: RNA FISH for Locating lncRNA-SNHG6 in Osteosarcoma Cells
Published on: June 16, 2023
Long non-coding RNA HAND2-AS1 targets glucose metabolism and inhibits cancer cell proliferation in osteosarcoma
Shunguang Chen1, Xiaoming Xu1, Shengjun Lu1
1Department of Orthopedics, Jingzhou Central Hospital, Jingzhou, Hubei 434020, P.R. China.
Abstract:
Long non-coding RNA heart and neural crest derivatives expressed 2-antisense RNA 1 (lncRNA HAND2-AS1) is a known tumor suppressor gene in endometrioid endometrial carcinoma; however, its function in osteosarcoma is currently unknown. In the present study, HAND2-AS1 expression in the tumor tissues and adjacent healthy tissues of patients with osteosarcoma, and in the serum of patients and heathy controls was detected by reverse transcription-quantitative polymerase chain reaction. lncRNA HAND2-AS1 small interfering RNA was transfected into osteosarcoma cells, and cell proliferation, glucose transporter 1 (GLUT1) expression and glucose uptake were detected using the Cell Counting Kit-8, western blotting and glucose uptake assays, respectively. The results revealed that the expression levels of HAND2-AS1 were reduced in cancer tissues compared with those in healthy tissues. Levels of HAND2-AS1 were also reduced in the serum of patients with osteosarcoma compared with those of the control subjects. A significant association was observed between serum levels of HAND2-AS1 and tumor size, but not tumor metastasis. HAND2-AS1-knockdown promoted osteosarcoma cell proliferation, increased glucose uptake and upregulated GLUT1 expression. It was therefore concluded that lncRNA HAND2-AS1 may inhibit the proliferation of osteosarcoma cells by targeting glucose metabolism.
Insights
Long non-coding RNA HAND2-AS1 (lncRNA HAND2-AS1) acts as a tumor suppressor in osteosarcoma. Reduced HAND2-AS1 levels promote cancer cell proliferation by increasing glucose metabolism, suggesting its therapeutic potential.
Area of Science:
- Oncology
- Molecular Biology
- Biochemistry
Background:
- Long non-coding RNA heart and neural crest derivatives expressed 2-antisense RNA 1 (lncRNA HAND2-AS1) is a known tumor suppressor in endometrial carcinoma.
- The role of lncRNA HAND2-AS1 in osteosarcoma remains unexplored.
Purpose of the Study:
- To investigate the expression and function of lncRNA HAND2-AS1 in osteosarcoma.
- To determine the relationship between lncRNA HAND2-AS1 and osteosarcoma progression.
Main Methods:
- Reverse transcription-quantitative polymerase chain reaction (RT-qPCR) to detect HAND2-AS1 expression in tumor tissues and serum.
- Transfection of osteosarcoma cells with HAND2-AS1 small interfering RNA (siRNA).
- Cell Counting Kit-8, western blotting, and glucose uptake assays to assess cell proliferation, glucose transporter 1 (GLUT1) expression, and glucose uptake.
Main Results:
- HAND2-AS1 expression was significantly reduced in osteosarcoma tissues and serum compared to healthy controls.
- Lower serum HAND2-AS1 levels correlated with larger tumor size.
- HAND2-AS1 knockdown promoted osteosarcoma cell proliferation, increased glucose uptake, and upregulated GLUT1 expression.
Conclusions:
- lncRNA HAND2-AS1 functions as a tumor suppressor in osteosarcoma.
- HAND2-AS1 may inhibit osteosarcoma cell proliferation by regulating glucose metabolism via GLUT1.
- Serum HAND2-AS1 levels could serve as a potential biomarker for osteosarcoma tumor size.
Related Concept Videos
lncRNA - Long Non-coding RNAs
Feedback Inhibition
Targeted Cancer Therapies
There are several types of targeted therapies against...
Cells Coordinate Growth and Proliferation
RNA Splicing
What is Metabolism?

